By Robert Jamerson Zacks upgraded shares of MiMedx Group (NASDAQ:MDXG) from a hold rating to a strong-buy rating in a report issued on Friday. They currently have $11.00 target price on the stock. Zacks’ analyst wrote, “MiMedx Group, Inc. (MiMedx Group) is a development stage company that